We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GLABF market cap is 24.76M. The company's latest EPS is CAD -0.0710 and P/E is -4.79.
| Year End January 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 219k | 0 | 0 |
| Operating Income | -436k | -4.25M | -5.71M | -4.95M |
| Net Income | -834k | -4.74M | -5.98M | -5.22M |
| Year End January 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 2.53M | 1.42M | 1.88M | 1.46M |
| Total Liabilities | 2.37M | 476k | 1.95M | 3.04M |
| Total Equity | 160k | 944k | -72k | -1.59M |
| Year End January 30 2024 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -320k | -3.87M | -4.51M | -3.24M |
| Investing | 14k | 8k | -505k | -41k |
| Financing | 1.19M | 4.14M | 3.94M | 3.2M |
| Market Cap | 24.76M |
| Price to Earnings Ratio | -4.79 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -15.77 |
| Dividend Yield | - |
| Shares Outstanding | 73.51M |
| Average Volume (1 week) | 2.5k |
| Average Volume (1 Month) | 2.5k |
| 52 Week Change | -18.98% |
| 52 Week High | 0.508 |
| 52 Week Low | 0.2376 |
| Spread (Intraday) | 0.12 (30.89%) |
| Company Name | Gemina Laboratories Ltd (QB) |
| Address |
10th floor, 595 howe street vancouver, british columbia |
| Website | https://www.geminalabs.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
